SH2 domain-containing protein tyrosine phosphatase-2 (SHP-2) prevents cardiac remodeling after myocardial infarction through ERK/SMAD signaling pathway-Reference-Cited by-同舟云学术

SH2 domain-containing protein tyrosine phosphatase-2 (SHP-2) prevents cardiac remodeling after myocardial infarction through ERK/SMAD signaling pathway

Published:2021-01-08 Issue:2 Volume:34 Page:325-334
ISSN:1749-0774
Container-title:Human Cell
language:en
Short-container-title:Human Cell

Author:

Lu Yong-Gang,Tan He,Ma Qian,Li Xin-Xin,Cui Jia,Zhang Xue,Liang Xue-Lei,Tie Yan-Qing

Funder

Prevention and Control of Geriatric Diseases in 2018

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Cell Biology

Link

http://link.springer.com/content/pdf/10.1007/s13577-020-00430-x.pdf

Reference32 articles.

1. Khan M, Kwiatkowski P, Rivera BK, Kuppusamy P. Oxygen and oxygenation in stem-cell therapy for myocardial infarction. Life Sci. 2010;87(9–10):269–74.

2. Martínez-Martínez E, Buonafine M, Boukhalfa I, Ibarrola J, Fernández-Celis A, Kolkhof P, et al. Aldosterone target NGAL (Neutrophil Gelatinase-Associated Lipocalin) is involved in cardiac remodeling after myocardial infarction through NFκB pathway. Hypertension (Dallas, Tex: 1979). 2017;70(6):1148–56. https://doi.org/10.1161/hypertensionaha.117.09791.

3. Frangogiannis NG. The inflammatory response in myocardial injury, repair, and remodelling. Nat Rev Cardiol. 2014;11(5):255–65. https://doi.org/10.1038/nrcardio.2014.28.

4. Huang S, Frangogiannis NG. Anti-inflammatory therapies in myocardial infarction: failures, hopes and challenges. Br J Pharmacol. 2018;175(9):1377–400. https://doi.org/10.1111/bph.14155.

5. Frangogiannis NG. The role of transforming growth factor (TGF)-β in the infarcted myocardium. J Thorac Dis. 2017;9(Suppl 1):S52–s63. https://doi.org/10.21037/jtd.2016.11.19.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. YinChen WuLing powder attenuates non-alcoholic steatohepatitis through the inhibition of the SHP2/PI3K/NLRP3 pathway;Frontiers in Pharmacology;2024-07-19

2. sFgl2 gene-modified MSCs regulate the differentiation of CD4+ T cells in the treatment of autoimmune hepatitis;Stem Cell Research & Therapy;2023-11-03

3. Comparative Analysis of Heart Regeneration: Searching for the Key to Heal the Heart—Part II: Molecular Mechanisms of Cardiac Regeneration;Journal of Cardiovascular Development and Disease;2023-08-22

4. Post-myocardial infarction fibrosis: Pathophysiology, examination, and intervention;Frontiers in Pharmacology;2023-03-28

5. G Protein-Coupled Receptor Kinase 2 as Novel Therapeutic Target in Fibrotic Diseases;Frontiers in Immunology;2022-01-17